Generic Name: Ranibizumab
Brand Name: Lucentis
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Indications: Choroidal neovascularisation, myopic
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: February 19, 2015
Recommendation Type: List with criteria/condition